The FDA has approved Tremfya (guselkumab) for the treatment of adults with moderately to severely active Crohn disease.
Recommendation based on the findings from the Phase 3 studies (GALAXI programme and GRAVITI) in Crohn's disease 1,2< ...
Studies show how some plant foods can reduce inflammation, prevent flare-ups and even lower surgery risks for those with Crohn's disease and ulcerative colitis.
Silent Crohn’s disease may have little or no symptoms. It's important to monitor disease activity and treat the condition to ...
The U.S. Food and Drug Administration has approved Johnson & Johnson's Tremfya (guselkumab) for adult patients with ...
Tremfya is also approved to treat patients with plaque psoriasis, active psoriatic arthritis and ulcerative colitis and is ...
7d
Zacks Investment Research on MSNPharma Stock Roundup: PFE's Final Haleon Stake Sale, AZN, SNY M&A DealsThis week, the FDA approved J&J’s JNJ Tremfya for its second inflammatory bowel disease (“IBD”) condition, Crohn’s disease ...
With another inflammatory bowel disease (IBD) approval in the bag for Tremfya, Johnson & Johnson continues to make good on ...
Hundreds of common foods in the US contain an additive linked to a mysterious illness in children. Tortillas, spices, salad dressings, gum, protein bars and other items contain glycerol ...
What Is Hypertensive Heart Disease? Your heart beats around 100,000 ... and making small changes to your daily habits. Make healthy food choices. That includes limiting the amount of sodium ...
Background: In recent years, the incidence of Crohn's disease has risen significantly in the pediatric population, and its prolongation has had a major impact on children's physical and mental health ...
Crohn's disease, a debilitating inflammatory bowel disease, has many known contributing factors, including bacterial changes in the microbiome that foster an inflammatory environment. Now ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results